Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT).
Kusuma FK, Prabhu A, Tieo G, Ahmed SM, Dakle P, Yong WK, Pathak E, Madan V, Jiang YY, Tam WL, Kappei D, Dröge P, Koeffler HP, Jeitany M.
Kusuma FK, et al. Among authors: madan v.
Nat Commun. 2023 Apr 6;14(1):1919. doi: 10.1038/s41467-023-37633-3.
Nat Commun. 2023.
PMID: 37024489
Free PMC article.